ZBIO
ZBIO
NASDAQ · Biotechnology

Zenas Biopharma Inc

$19.64
+0.37 (+1.92%)
As of May 9, 9:39 PM ET ·
Financial Highlights (FY 2026)
Revenue
12.95M
Net Income
-489,249,313
Gross Margin
Profit Margin
-3,777.4%
Rev Growth
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.1% 63.1% 63.1%
Operating Margin -3,830.6% -0.1% -0.1% -0.1%
Profit Margin -3,777.4% -0.1% -0.1% -0.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 12.95M 140.52M 130.81M 124.82M
Gross Profit 88.66M 82.54M 78.75M
Operating Income -496,222,035 -128,018 -131,088 -117,084
Net Income -489,249,313 -116,113 -126,311 -113,132
Gross Margin 63.1% 63.1% 63.1%
Operating Margin -3,830.6% -0.1% -0.1% -0.1%
Profit Margin -3,777.4% -0.1% -0.1% -0.1%
Rev Growth -3.7% +16.0% -9.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 137.46M 299.15M 339.29M 361.86M
Total Equity 423.35M 337.93M 370.10M 341.01M
D/E Ratio 0.32 0.89 0.92 1.06
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -495,529,465 -178,287 -168,053 -162,378
Free Cash Flow -139,366 -118,293 -114,579